Evidence map›Paper›PMID 23752178›Full record

ArticleOncogene2014

Utility of a bacterial infection model to study epithelial-mesenchymal transition, mesenchymal-epithelial transition or tumorigenesis.

P Chandrakesan, B Roy, L U M R Jakkula, I Ahmed, P Ramamoorthy, O Tawfik, R Papineni, C Houchen, S Anant, S Umar

Open access · bronzeAbstract read
In one paragraph

Article in Oncogene, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed
3.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 81 citations in OpenAlex.

  1. The divergentMicrobiology (Reading, England) · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

P ChandrakesanDivision of Gastroenterology, Department of Internal Medicine, Oklahoma City, OK, USA.
B RoyDepartment of Molecular and Integrative Physiology, University of Kansas Medical Center, Kansas City, KS, USA.
L U M R JakkulaDepartment of Molecular and Integrative Physiology, University of Kansas Medical Center, Kansas City, KS, USA.
I AhmedDepartment of Molecular and Integrative Physiology, University of Kansas Medical Center, Kansas City, KS, USA.
P RamamoorthyDepartment of Molecular and Integrative Physiology, University of Kansas Medical Center, Kansas City, KS, USA.
O TawfikDepartment of Anatomic and Surgical Pathology, University of Kansas Medical Center, Kansas City, KS, USA.
R PapineniCarestream Molecular Imaging, Woodbridge, CT, USA.
C HouchenDivision of Gastroenterology, Department of Internal Medicine, Oklahoma City, OK, USA.
S Anant1] Department of Molecular and Integrative Physiology, University of Kansas Medical Center, Kansas City, KS, USA [2] The University of Kansas Cancer Center, University of Kansas Medical Center, Kansas City, KS, USA.
S Umar1] Department of Molecular and Integrative Physiology, University of Kansas Medical Center, Kansas City, KS, USA [2] The University of Kansas Cancer Center, University of Kansas Medical Center, Kansas City, KS, USA.
University of Kansas Medical Center · USOklahoma City University · USCarestream (United States) · USThe University of Kansas Cancer Center · US

Funding

Intestinal Stem Cell Consortium Coordinating CenterU01DK085532 · NIDDK · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI NILAND, JOYCE CAROL · 2009 to 2018
$6.5M
Limited Competition for the Continuation of the Intestinal Stem Cell Consortium Coordinating CenterU24DK085532 · NIDDK · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI NILAND, JOYCE CAROL · 2019 to 2023
$2.3M
Isolation and Characterization of Intestinal Stem Cells Using Novel Markers (RP)U01DK085508 · NIDDK · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI HOUCHEN, COURTNEY WAYNE · 2009 to 2014
$2.0M
Beta-Catenin/NF-kB in Hyperplasia/Neoplasia of Colonic Crypts: ChemopreventionR01CA131413 · NCI · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI UMAR, SHAHID · 2008 to 2011
$1.2M
NCI NIH HHS R01 CA131413NIDDK NIH HHS U01 DK085508NIDDK NIH HHS U01DK085508-04S1NIDDK NIH HHS U01 DK085532NIDDK NIH HHS U24 DK085532
6 · The paper itself

Abstract

DCLK1 and Lgr5 have recently been identified as markers of quiescent and cycling stem cells in the small intestinal crypts, respectively. Epithelial-mesenchymal transition (EMT) is a key development program that is often activated during cancer invasion and metastasis, and also imparts a self-renewal capability to disseminating cancer cells. Utilizing the Citrobacter rodentium (CR)-induced transmissible murine colonic hyperplasia (TMCH) model, we observed a relative decrease in DCLK1 expression in the colonic crypts, with significant shift towards stromal staining at peak (12 days post infection) hyperplasia, whereas staining for Lgr5 and Msi-1 increased several fold. When hyperplasia was regressing (days 20-34), an expansion of DCLK1+ve cells in the CR-infected crypts compared with that seen in uninfected control was recorded. Purified colonic crypt cells exhibiting epigenetic modulation of the transforming growth factor-β (TGFβ), Wnt and Notch pathways on 12 or 34 days post infection formed monolayers in vitro, and underwent trans-differentiation into fibroblast-like cells that stained positive for vimentin, fibronectin and DCLK1. These cells when trypsinized and regrown in soft agar, formed colonospheres/organoids that developed into crypt-like structures (colonoids) in Matrigel and stained positive for DCLK1. Mice exhibiting 12 or 34 days of TMCH were given azoxymethane once for 8 h (Gp1) or weekly for 3 weeks (Gp2), and subjected to crypt isolation. Crypt cells from Gp1 animals formed monolayers as well as colonospheres in soft agar and nodules/tumors in nude mice. Crypt cells isolated from Gp2 animals failed to form the monolayers, but developed into colonospheres in soft agar and nodules/tumors in nude mice. Thus, both hyperplasia and increased presence of DCLK1+ve cells promote cellular transformation in response to a second hit. The TMCH model, therefore, provides an excellent template to study how alterations in intestinal stem cells promote trans-differentiation, crypt regeneration or colon carcinogenesis following bacterial infection.

Indexed as

CarcinogenesisDisease Models, AnimalEpithelial-Mesenchymal TransitionAnimalsAzoxymethaneBacterial InfectionsCell DifferentiationColonEpigenesis, GeneticMiceMice, NudeReceptors, NotchSignal TransductionStem CellsWnt ProteinsAzoxymethaneReceptors, NotchWnt Proteins

Identifiers

PMID23752178
PMCPMC3883801
OpenAlexW2054736207

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.